This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Act now: the analyst who called NVIDIA in 2010 just named ...

Abstract: This paper proposes an innovative recursive filtering algorithm for nonlinear microseismic systems with signal attenuation. Firstly, the microseismic wavelet and nearby noise are modeled as ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...

Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...

AI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone. Recursion was able to use its artificial intelligence-enabled drug discovery ...

Recursion Pharmaceuticals has agreed to acquire the Oxford, U.K.-based artificial intelligence (AI) drug pioneer Exscientia, the companies said today, in a deal that consolidates two leaders in ...

Recursion and Exscientia, two artificial intelligence firms, on Thursday announced that they would combine, betting their complementary skills in technology-based drug discovery will lead to faster ...